In many cases, yes, particularly when medical necessity is documented
Epitalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG), studied as a reagent in cellular-aging research
Young people, such as 18-year-old gym-goers, are already using BPC, and it is a concern because they may not need it, as their bodies already produce the necessary peptides, and this is supported by parabiosis studies 2m6s
This shuttle ensures efficient oxidation of fatty acids in energy-dependent tissues such as skeletal muscle and myocardium
Clinical trials using imaging techniques demonstrate that GLP-1 medications significantly reduce visceral adipose tissue alongside overall weight loss
But what we are seeing is that GLP-1 coverage is getting more accessible for specific conditions sleep apnea, diabetes, extremely high BMI or a combination of these things but for other conditions, coverage is probably going to get more restrictive